The proposed bill aims to restore public trust in health messaging by ensuring that all communications related to Food and Drug Administration (FDA)-regulated products adhere strictly to the promotional guidelines set forth by the FDA. It highlights the importance of accurate and truthful information regarding public health interventions, particularly in light of the COVID-19 pandemic, where it claims that various government entities overstated the benefits of certain health measures, leading to a decline in public confidence. The bill mandates that the Washington State Department of Health, other executive branch actors, and local health departments can only promote FDA-regulated products in compliance with FDA labeling conditions, and any misleading information must be corrected promptly.

To enforce these standards, the bill establishes internal review processes for compliance, requires annual reporting to the state auditor, and outlines disciplinary actions for violations, including potential termination of employees. It also stipulates that any preexisting materials that do not conform to these new requirements must be withdrawn within 30 days. The bill emphasizes the need for transparency and accountability in public health communications, aiming to prevent the dissemination of unproven claims and restore credibility in health messaging.